Archive for July 2020

DNA Methylation Multivariate Biomarkers Offers 98% Specificity and Sensitivity July 28, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer, is pleased to announce the filing of a provisional patent for the company’s lead diagnostic test – BreastDefense.…

July 8, 2020 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced diagnostic test to identify invasive breast cancer has retained Zimmons International Communications, Inc. (“Zimmons International”), based in New York City, as the company”‘s financial communications counselor and investor relations firm. Zimmons International will assist SignPost…